Personalizing treatment for narcolepsy requires shared decision-making between patients and clinicians to understand the most important symptoms that need to be treated and the right therapy, said Michael Thorpy, MD, director of the Sleep-Wake Disorders Center at Montefiore Medical Center and professor of neurology at Albert Einstein College of Medicine.
Personalizing treatment for narcolepsy requires shared decision-making between patients and clinicians to understand the most important symptoms that need to be treated and the right therapy, said Michael Thorpy, MD, director of the Sleep-Wake Disorders Center at Montefiore Medical Center and professor of neurology at Albert Einstein College of Medicine.
Transcript
How can clinicians ensure their patients’ voices are heard when it comes to aligning treatment goals for narcolepsy?
We're really entering into a stage of personalized medicine for patients with narcolepsy, and it's most important that clinicians really listen to their patients, understand the symptoms that they're having, the severity of those symptoms, and which are the most important ones. Narcolepsy has a number of different symptoms associated with it—there can be the excessive daytime sleepiness, the cataplexy, or the disturbed nocturnal sleep. And it's good for the clinician to recognize which of those conditions most affect the patient, and which are the ones that the patient feels that they need to get under control.
Because the management of narcolepsy involves a lot of new medications, it's important that the patient understands the differences between the medications and the treatments that are available to them. The clinician really needs to move into shared decision-making with the patient when it comes to the management of narcolepsy. Very often the treatment of narcolepsy involves not just one medication, but it may involve multiple medications. The patients need to understand that as to the interactions potentially, between these medications, and the interactions with other medications that they may be taking.
Narcolepsy is also associated with a lot of comorbidity illnesses—psychiatric illnesses, anxiety, and depression. Patients may be on medications to treat those conditions, and patients need to understand how their narcolepsy medications will interact with those medications. There's also new evidence with regards to comorbidities and cardiovascular disorders and some of the newer medications that can have an adverse effect upon cardiovascular parameters.
So, again, the most important thing in treating patients is to have that patient involvement and their understanding of not only the symptoms but also the treatments that are available, and then join into a shared decision-making process to get the best treatment for them.
How can clinicians encourage their patients to share as much as possible about the symptoms they are experiencing?
The important thing is education. A lot of patients with narcolepsy really don't understand the symptoms, and they've often lived with them for a number of years. They may underestimate the effect of these symptoms upon their daily life. It's important for the physician to address the different symptoms of narcolepsy and to see how they impact the patient's quality of life, their work, and their interpersonal relationships. So, discussing the impact of those symptoms is the most important thing in deciding which is the best direction to go in terms of management.
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
2 Commerce Drive
Cranbury, NJ 08512